Structure-guided design of a “bump-and-hole” bromodomain-based degradation tag
Chemical biology tools to modulate protein levels in cells are critical to decipher complex
biology. Targeted protein degradation offers the potential for rapid and dose-dependent …
biology. Targeted protein degradation offers the potential for rapid and dose-dependent …
Design of Class I/IV Bromodomain-Targeting Degraders for Chromatin Remodeling Complexes
H Zahid, JP Costello, Y Li, JR Kimbrough… - ACS Chemical …, 2023 - ACS Publications
Targeted protein degradation is an emerging technology that can be used for modulating the
activity of epigenetic protein targets. Among bromodomain-containing proteins, a number of …
activity of epigenetic protein targets. Among bromodomain-containing proteins, a number of …
Development of an n-terminal brd4 bromodomain-targeted degrader
Targeted protein degradation is a powerful induced-proximity tool to control cellular protein
concentrations using small molecules. However, the design of selective degraders remains …
concentrations using small molecules. However, the design of selective degraders remains …
DCAF16-Based Covalent Handle for the Rational Design of Monovalent Degraders
M Lim, TD Cong, LM Orr, ES Toriki, AC Kile… - ACS Central …, 2024 - ACS Publications
Targeted protein degradation with monovalent molecular glue degraders is a powerful
therapeutic modality for eliminating disease causing proteins. However, rational design of …
therapeutic modality for eliminating disease causing proteins. However, rational design of …
Discovery of novel small molecule induced selective degradation of the bromodomain and extra-terminal (BET) bromodomain protein BRD4 and BRD2 with cellular …
F Jiang, Q Wei, H Li, H Li, Y Cui, Y Ma, H Chen… - Bioorganic & medicinal …, 2020 - Elsevier
Abstract The BET proteins BRD2, BRD3, and BRD4 play important roles in transcriptional
regulation and can be degraded by proteolysis-targeting chimeras (PROTACs) for BET …
regulation and can be degraded by proteolysis-targeting chimeras (PROTACs) for BET …
Selectively targeting proteins for degradation
S Crunkhorn - Nature Reviews Drug Discovery, 2015 - nature.com
Ligand-induced target protein degradation has emerged as a promising therapeutic
strategy, particularly in cancer, but efforts so far have often been limited by various factors …
strategy, particularly in cancer, but efforts so far have often been limited by various factors …
Precise conformational control yielding highly potent and exceptionally selective BRD4 degraders with strong antitumor activity
Starting from a nonselective bromodomain and extraterminal (BET) inhibitor and a cereblon
ligand, we have used precise conformational control for the development of two potent and …
ligand, we have used precise conformational control for the development of two potent and …
Impact of target warhead and linkage vector on inducing protein degradation: comparison of bromodomain and extra-terminal (BET) degraders derived from …
The design of proteolysis-targeting chimeras (PROTACs) is a powerful small-molecule
approach for inducing protein degradation. PROTACs conjugate a target warhead to an E3 …
approach for inducing protein degradation. PROTACs conjugate a target warhead to an E3 …
[HTML][HTML] Targeted degradation via direct 26S proteasome recruitment
C Bashore, S Prakash, MC Johnson… - Nature Chemical …, 2023 - nature.com
Engineered destruction of target proteins by recruitment to the cell's degradation machinery
has emerged as a promising strategy in drug discovery. The majority of molecules that …
has emerged as a promising strategy in drug discovery. The majority of molecules that …
[HTML][HTML] Translating PROTAC chemical series optimization into functional outcomes underlying BRD7 and BRD9 protein degradation
KM Riching, JD Vasta, SJ Hughes, V Zoppi… - Current Research in …, 2021 - Elsevier
Proteolysis targeting chimeras (PROTACs) are complex molecules to design and optimize
as degraders, primarily because the linker that bridges the two binding ligands is a highly …
as degraders, primarily because the linker that bridges the two binding ligands is a highly …